Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04754022 · ClinicalTrials.gov registry record · NA

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

A NA study of Cardiac Surgery and Post Operative, sponsored by Unity Health Toronto.

Recruiting
Registry status
NA
Development phase
1,440
Enrollment target
20
Study locations

NCT04754022: Recruiting NA study of Cardiac Surgery and Post Operative, sponsored by Unity Health Toronto.

NCT04754022 is a NA study of Cardiac Surgery and Post Operative that is actively recruiting participants, run by Unity Health Toronto. The registered enrollment target is 1,440 participants, above the 670-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (115% higher). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04754022, a NA study of Cardiac Surgery and Post Operative, is actively recruiting participants, sponsored by Unity Health Toronto.

RECRUITING
Registry status
NA
Development phase
1,440 participants
Enrollment target
20
Study locations

Study Summary

TRICS-IV is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in moderate to high risk patients who are 65 years of age or younger undergoing cardiac surgery on cardiopulmonary bypass, using a superiority trial design.

Primary Outcome

Any of all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, or new focal neurological deficit (stroke).

Interventions

  • OTHER Restrictive Transfusion Strategy
  • OTHER Liberal transfusion strategy

Study Locations (20)

New South Wales

  • Royal Prince Alfred hospital - Camperdown
  • Prince of Wales Hospital - Randwick
  • Westmead Hospital - Westmead

Victoria

  • Monash Health - Clayton
  • St Vincent's Hospital Melbourne - Fitzroy
  • Austin Health - Heidelberg

Other

  • Royal Melbourne Hospital - Melbourne
  • Alfred Hospital - Prahran

British Columbia

  • Interior Health Kelowna General Hospital - Kelowna
  • Vancouver General Hospital - Vancouver

Maine

  • Maine Medical Center - Portland

New Jersey

  • The Cooper Health System - Camden

New York

  • Columbia University - New York

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 1,440 participants
Start Date 2021-11-01
Est. Completion 2026-06
Phase NA
Unity Health Toronto

12 total trials

What NCT04754022 shows while recruiting

NCT04754022 is an interventional study that assigns participants to a tested intervention. Its 1,440 participants enrollment target places it among the larger protocols in the corpus, above the 670-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (115% higher).

The record links to 4 conditions, with Cardiac Surgery appearing as the primary indexed condition, and to 2 interventions - of which Restrictive Transfusion Strategy is the first listed.

NCT04754022 names 20 study sites across 14 states, led by New South Wales, Victoria, Other.

Frequently Asked Questions

What is clinical trial NCT04754022 about?

NCT04754022 is a clinical study titled "Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery". TRICS-IV is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in moderate to high risk patients who are 65 years of age or younger undergoing cardiac surgery on cardiopulmonary bypass, using a superiority trial design.

What is the current status of trial NCT04754022?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,440 participants. The study started on 2021-11-01. Estimated completion is 2026-06.

What conditions does trial NCT04754022 study?

This clinical trial studies the following conditions: Cardiac Surgery, Post Operative, Heart, Disorder.

What interventions are being tested in trial NCT04754022?

The interventions under investigation include: Restrictive Transfusion Strategy (OTHER), Liberal transfusion strategy (OTHER).

Who is sponsoring clinical trial NCT04754022?

This trial is sponsored by Unity Health Toronto, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04754022 being conducted?

This trial has 20 study locations across Maine, New Jersey, New York, Pennsylvania, Adelaide. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04754022's enrollment target sits among peer trials

1,440 4th of 19 higher than 16 of 19 other Cardiac Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiac Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04989790 · 1,440 participants · NA

    Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children

  • NCT06122246 · 1,440 participants · NA

    PRESSURE CHECK: Find Your Path to Better Health

  • NCT06324318 · 1,440 participants · Phase 2

    Parenting in 2 Worlds Multisite Trial

  • NCT06814509 · 1,440 participants · NA

    Delivering HOPE (Helping Women Optimize Prenatal Equity)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04754022, the US trial registry maintained by the National Library of Medicine. NCT04754022 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.